Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Modabber

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Infection and Immunity|December 19, 2000
Vervet monkeys vaccinated with killed Leishmania major parasites and interleukin-12 develop a type 1 immune response but are not protected against challenge infectionM M Gicheru, J O Olobo, C O Anjili, et al.
Bulletin of the World Health Organization|July 12, 2003
Treatment of cutaneous leishmaniasis with aminosidine (paromomycin) ointment: double-blind, randomized trial in the Islamic Republic of IranA Asilian, T Jalayer, M Nilforooshzadeh, et al.
Clinical and Experimental Immunology|November 18, 2003
Immune response measured in human volunteers vaccinated with autoclaved Leishmania major vaccine mixed with low dose of BCGM Mahmoodi, A Khamesipour, Y Dowlati, et al.
Memorias Do Instituto Oswaldo Cruz|August 12, 1998
Phase 1 study of an inactivated vaccine against American tegumentary leishmaniasis in normal volunteers in BrazilK B Marzochi, M A Marzochi, A F Silva, et al.
Leprosy Review|December 1, 1980
Preliminary immunological studies in search of correlates of protective immunity carried out on some Iranian leprosy patients and their familiesJ L Stanford, G A Rook, N Samuel, et al.
Clinics in Dermatology|September 1, 1996
Comparative safety and immunogenicity trial of two killed Leishmania major vaccines with or without BCG in human volunteersK Bahar, Y Dowlati, B Shidani, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 6, 1997
Efficacy of sodium stibogluconate alone and in combination with allopurinol for treatment of mucocutaneous leishmaniasisA Llanos-Cuentas, J Echevarría, M Cruz, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|February 24, 2001
Safety and immunogenicity of a killed Leishmania (L.) amazonensis vaccine against cutaneous leishmaniasis in Colombia: a randomized controlled trialI D Vélez, S del Pilar Agudelo, M P Arbelaez, et al.
Lancet (London, England)|May 18, 1999
Randomised vaccine trial of single dose of killed Leishmania major plus BCG against anthroponotic cutaneous leishmaniasis in Bam, IranI Sharifi, A R FeKri, M R Aflatonian, et al.
Lancet (London, England)|November 15, 2000
Autoclaved Leishmania major vaccine for prevention of visceral leishmaniasis: a randomised, double-blind, BCG-controlled trial in SudanE A Khalil, A M El Hassan, E E Zijlstra, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Infection and Immunity|December 19, 2000
Vervet monkeys vaccinated with killed Leishmania major parasites and interleukin-12 develop a type 1 immune response but are not protected against challenge infectionM M Gicheru, J O Olobo, C O Anjili, et al.
Bulletin of the World Health Organization|July 12, 2003
Treatment of cutaneous leishmaniasis with aminosidine (paromomycin) ointment: double-blind, randomized trial in the Islamic Republic of IranA Asilian, T Jalayer, M Nilforooshzadeh, et al.
Clinical and Experimental Immunology|November 18, 2003
Immune response measured in human volunteers vaccinated with autoclaved Leishmania major vaccine mixed with low dose of BCGM Mahmoodi, A Khamesipour, Y Dowlati, et al.
Memorias Do Instituto Oswaldo Cruz|August 12, 1998
Phase 1 study of an inactivated vaccine against American tegumentary leishmaniasis in normal volunteers in BrazilK B Marzochi, M A Marzochi, A F Silva, et al.
Leprosy Review|December 1, 1980
Preliminary immunological studies in search of correlates of protective immunity carried out on some Iranian leprosy patients and their familiesJ L Stanford, G A Rook, N Samuel, et al.
Clinics in Dermatology|September 1, 1996
Comparative safety and immunogenicity trial of two killed Leishmania major vaccines with or without BCG in human volunteersK Bahar, Y Dowlati, B Shidani, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 6, 1997
Efficacy of sodium stibogluconate alone and in combination with allopurinol for treatment of mucocutaneous leishmaniasisA Llanos-Cuentas, J Echevarría, M Cruz, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|February 24, 2001
Safety and immunogenicity of a killed Leishmania (L.) amazonensis vaccine against cutaneous leishmaniasis in Colombia: a randomized controlled trialI D Vélez, S del Pilar Agudelo, M P Arbelaez, et al.
Lancet (London, England)|May 18, 1999
Randomised vaccine trial of single dose of killed Leishmania major plus BCG against anthroponotic cutaneous leishmaniasis in Bam, IranI Sharifi, A R FeKri, M R Aflatonian, et al.
Lancet (London, England)|November 15, 2000
Autoclaved Leishmania major vaccine for prevention of visceral leishmaniasis: a randomised, double-blind, BCG-controlled trial in SudanE A Khalil, A M El Hassan, E E Zijlstra, et al.
Pageof 4